Reports
Reports
Analysts’ Viewpoint
Increase in demand for personalized medicines and rise in number of clinical trials are the key factors boosting central lab market development. Surge in prevalence of chronic diseases such as diabetes and cancer and growth in need for accurate and reliable diagnostic services are also fueling central lab market dynamics.
Adoption of advanced technologies, such as automation and Artificial Intelligence, is expected to drive central lab industry growth in the next few years. However, high cost of central lab services and lack of skilled professionals are likely to restrain market growth to some extent. Key players operating in the global market are focusing on strategic collaborations and partnerships to enhance product offerings and expand their global footprint.
Central diagnostic laboratory is a vital component of the healthcare industry, as it provides essential services to pharmaceutical and biotech companies. Central labs are specialized facilities that offer a range of services, including clinical trial testing, biomarker analysis, and drug development support. These labs are equipped with advanced technologies and highly skilled professionals who work together to provide accurate and reliable results.
Central laboratory services include bioanalytical testing, clinical chemistry, hematology, microbiology, and molecular diagnostics. These services are essential for drug development and clinical trials, as they help identify potential safety issues and ensure the efficacy of new drugs.
Central labs offer a range of advantages, including standardized testing protocols, centralized data management, and faster turnaround times.
Clinical trials are an essential part of drug development. Central labs provide various services such as sample collection, testing, analysis, and reporting to support clinical trial activities.
The global central lab business is growing at a rapid pace due to the increase in prevalence of chronic diseases and rise in aging population. As a result, demand for new drugs that help treat these diseases effectively is rising significantly. This has led to an increase in number of clinical trials being conducted globally.
Regulatory organizations of different countries have made it mandatory for pharmaceutical companies to conduct extensive clinical trials before launching any new drug in the market. Such regulations ensure that drugs are safe and effective before they reach patients.
Central labs play a crucial role in supporting these clinical trials by providing accurate and reliable data on drug efficacy and safety. They help pharmaceutical companies meet regulatory requirements while ensuring patient safety.
Advancements in technologies, such as electronic data capture (EDC) systems and cloud-based platforms, have allowed central labs to offer more efficient services at lower costs than traditional methods. This has further increased their popularity among pharmaceutical companies conducting clinical trials.
Personalized medicine involves offering medical treatment based on a patient’s genetic information. Personalized medicine offers several benefits over traditional approaches such as improved treatment outcomes with fewer side effects, which lead to a better quality of life for patients suffering from chronic conditions.
Personalized medicine also reduces healthcare costs through targeted therapies, which help reduce unnecessary treatments or hospitalizations.
Central labs play a key role in supporting personalized medicines by providing accurate and reliable data on patient characteristics such as genetics, biomarkers, and other diagnostic tests. This information is used to develop targeted therapies that are more effective than traditional approaches.
Rise in prevalence of chronic diseases such as cancer and diabetes has boosted the demand for personalized medicines. According to the World Health Organization (WHO), cancer is one of the leading causes of death across the globe. Personalized medicines offer hope for better treatment outcomes for these patients.
The genetic services product segment accounted for significant market share in 2022. It is expected to dominate in the near future. Increase in demand for personalized medicines is one of the key factors driving the segment.
Advancements in technology have made genetic testing faster and more affordable. For instance, Illumina, Inc., a leading provider of DNA sequencing technology, announced the launch of its new NovaSeq 6000 Sequencing System in January 2017. The system can sequence up to 48 human genomes per run at a lower cost than previous systems.
Such technological advancements have enabled central labs to offer genetic testing services at competitive prices, thereby boosting central lab market growth.
The pharmaceutical companies end-user segment is estimated to account for major share of the global market in the near future. Pharmaceutical companies are taking efforts to reduce the cost of development and manufacture of drugs.
Central lab services can be outsourced by these companies. Central lab services provide advanced technologies and use innovative processes. This helps in the drug development process. Central labs also prove more efficient and cost-effective for large multinational pharmaceutical companies in lowering the development cost of new drugs.
North America is anticipated to dominate the global central lab market during the forecast period, owing to the presence of well-established pharmaceutical companies and high adoption rate of advanced technologies.
Presence of leading players such as Laboratory Corporation of America Holdings (Labcorp), Quest Diagnostics, and Charles River Laboratories International, Inc. is also fueling market statistics in North America. The central lab market size in the region is projected to increase steadily in the next few years, owing to the favorable government initiatives aimed at improving healthcare facilities.
As per the latest central lab market forecast, Asia Pacific is likely to be one of the fastest-growing regions during the forecast period. This growth can be ascribed to the increase in investment by key players in the healthcare sector and rise in demand for clinical trials in the region.
Increase in population and rise in prevalence of chronic diseases in countries such as China and India are projected to fuel central lab market demand in Asia Pacific. Furthermore, low labor costs make it easier for companies to set up operations in the region.
The global landscape is fragmented, with the presence of several prominent companies that control majority of the central lab market share.
As per the central lab market research analysis, companies are focusing on strategies such as launch of new products, mergers & acquisitions (M&A), and partnerships to strengthen their position in the industry.
ACM Global Laboratories, Bioscientia (Sonic Healthcare), CIRION BioPharma Research, Eurofins Central Laboratory, ICON Central Laboratories, InVitro International, INTERLAB Central Lab Services, Labcorp/Covance, Medpace, PPD, MLM Medical Labs GmbH, Frontage Laboratories, Inc., Barc Lab (Cerba Research), Q² Solutions, Celerion, Clinical Reference Laboratory, and LabConnect are the leading central lab companies operating in this market.
Each of these players has been profiled in the central lab market report based on parameters such as financial overview company overview, latest developments, business strategies, business segments, and product portfolio.
|
Attribute |
Detail |
|---|---|
|
Market Value in 2022 |
US$ 2.6 Bn |
|
Market Forecast Value in 2031 |
More than US$ 4.1 Bn |
|
Compound Annual Growth Rate (CAGR) |
5.1% |
|
Forecast Period |
2023-2031 |
|
Historical Data Available for |
2017-2021 |
|
Quantitative Units |
US$ Bn for Value |
|
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
It was valued at US$ 2.6 Bn in 2022
It is projected to reach more than US$ 4.1 Bn by 2031
It is anticipated to grow at a CAGR of 5.1% from 2023 to 2031
Increase in complexity and number of clinical trials and rise in focus of companies on minimizing developmental cost of drugs
The genetic services product segment accounted for major share in 2022
North America is the most lucrative region
ACM Global Laboratories, Barc Lab (Cerba Research), Bioscientia (Sonic Healthcare), Celerion, CIRION BioPharma Research, Clinical Reference Laboratory, Eurofins Central Laboratory, Frontage Laboratories, Inc., ICON Central Laboratories, INTERLAB Central Lab Services, InVitro International, Labcorp/Covance, LabConnect, Medpace, MLM Medical Labs GmbH., PPD, and Q² Solutions
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Central Lab Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Central Lab Market Analysis and Forecast, 2017 - 2031
5. Key Insights
5.1. Strategies Adopted by Top 3 Players
5.2. Impact of Cell and Gene Therapy on Central Lab Market
5.3. Impact of Clinical Trial on Central Lab Market
5.4. COVID-19 Impact Analysis
6. Global Central Lab Market Analysis and Forecast, By Product
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Product, 2017 - 2031
6.3.1. Genetic Services
6.3.2. Biomarker Services
6.3.3. Microbiology Services
6.3.4. Anatomic Pathology/Histology
6.3.5. Specimen Management & Storage
6.3.6. Special Chemistry Services
6.3.7. Clinical Research & Trial Services
6.3.8. Others
6.4. Market Attractiveness By Product
7. Global Central Lab Market Analysis and Forecast, By End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By End-user, 2017 - 2031
7.3.1. Pharmaceutical Companies
7.3.2. Biotechnology Companies
7.3.3. Academic & Research Institutes
7.4. Market Attractiveness By End-user
8. Global Central Lab Market Analysis and Forecast, By Region
8.1. Key Findings
8.2. Market Value Forecast By Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness By Country/Region
9. North America Central Lab Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast By Product, 2017 - 2031
9.2.1. Genetic Services
9.2.2. Biomarker Services
9.2.3. Microbiology Services
9.2.4. Anatomic Pathology/Histology
9.2.5. Specimen Management & Storage
9.2.6. Special Chemistry Services
9.2.7. Clinical Research & Trial Services
9.2.8. Others
9.3. Market Value Forecast By End-user, 2017 - 2031
9.3.1. Pharmaceutical Companies
9.3.2. Biotechnology Companies
9.3.3. Academic & Research Institutes
9.4. Market Value Forecast By Country, 2017 - 2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Product
9.5.2. By End-user
9.5.3. By Country
10. Europe Central Lab Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast By Product, 2017 - 2031
10.2.1. Genetic Services
10.2.2. Biomarker Services
10.2.3. Microbiology Services
10.2.4. Anatomic Pathology/Histology
10.2.5. Specimen Management & Storage
10.2.6. Special Chemistry Services
10.2.7. Clinical Research & Trial Services
10.2.8. Others
10.3. Market Value Forecast By End-user, 2017 - 2031
10.3.1. Pharmaceutical Companies
10.3.2. Biotechnology Companies
10.3.3. Academic & Research Institutes
10.4. Market Value Forecast By Country, 2017 - 2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Product
10.5.2. By End-user
10.5.3. By Country
11. Asia Pacific Central Lab Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast By Product, 2017 - 2031
11.2.1. Genetic Services
11.2.2. Biomarker Services
11.2.3. Microbiology Services
11.2.4. Anatomic Pathology/Histology
11.2.5. Specimen Management & Storage
11.2.6. Special Chemistry Services
11.2.7. Clinical Research & Trial Services
11.2.8. Others
11.3. Market Value Forecast By End-user, 2017 - 2031
11.3.1. Pharmaceutical Companies
11.3.2. Biotechnology Companies
11.3.3. Academic & Research Institutes
11.4. Market Value Forecast By Country, 2017 - 2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Product
11.5.2. By End-user
11.5.3. By Country
12. Latin America Central Lab Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast By Product, 2017 - 2031
12.2.1. Genetic Services
12.2.2. Biomarker Services
12.2.3. Microbiology Services
12.2.4. Anatomic Pathology/Histology
12.2.5. Specimen Management & Storage
12.2.6. Special Chemistry Services
12.2.7. Clinical Research & Trial Services
12.2.8. Others
12.3. Market Value Forecast By End-user, 2017 - 2031
12.3.1. Pharmaceutical Companies
12.3.2. Biotechnology Companies
12.3.3. Academic & Research Institutes
12.4. Market Value Forecast By Country, 2017 - 2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Product
12.5.2. By End-user
12.5.3. By Country
13. Middle East & Africa Central Lab Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast By Product, 2017 - 2031
13.2.1. Genetic Services
13.2.2. Biomarker Services
13.2.3. Microbiology Services
13.2.4. Anatomic Pathology/Histology
13.2.5. Specimen Management & Storage
13.2.6. Special Chemistry Services
13.2.7. Clinical Research & Trial Services
13.2.8. Others
13.3. Market Value Forecast By End-user, 2017 - 2031
13.3.1. Pharmaceutical Companies
13.3.2. Biotechnology Companies
13.3.3. Academic & Research Institutes
13.4. Market Value Forecast By Country, 2017 - 2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Product
13.5.2. By End-user
13.5.3. By Country
14. Competition Landscape
14.1. Market Player - Competition Matrix (By Tier and Size of companies)
14.2. Market Share Analysis By Company (2022)
14.3. Company Profiles
14.3.1. ACM Global Laboratories
14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.1.2. Test Type Portfolio
14.3.1.3. Financial Overview
14.3.1.4. SWOT Analysis
14.3.1.5. Strategic Overview
14.3.2. Barc Lab (Cerba Research)
14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.2.2. Test Type Portfolio
14.3.2.3. Financial Overview
14.3.2.4. SWOT Analysis
14.3.2.5. Strategic Overview
14.3.3. Bioscientia (Sonic Healthcare)
14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.3.2. Test Type Portfolio
14.3.3.3. Financial Overview
14.3.3.4. SWOT Analysis
14.3.3.5. Strategic Overview
14.3.4. Celerion
14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.4.2. Test Type Portfolio
14.3.4.3. Financial Overview
14.3.4.4. SWOT Analysis
14.3.4.5. Strategic Overview
14.3.5. CIRION BioPharma Research
14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.5.2. Test Type Portfolio
14.3.5.3. Financial Overview
14.3.5.4. SWOT Analysis
14.3.5.5. Strategic Overview
14.3.6. Clinical Reference Laboratory
14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.6.2. Test Type Portfolio
14.3.6.3. Financial Overview
14.3.6.4. SWOT Analysis
14.3.6.5. Strategic Overview
14.3.7. Eurofins Central Laboratory
14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.7.2. Test Type Portfolio
14.3.7.3. Financial Overview
14.3.7.4. SWOT Analysis
14.3.7.5. Strategic Overview
14.3.8. Frontage Laboratories, Inc.
14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.8.2. Test Type Portfolio
14.3.8.3. Financial Overview
14.3.8.4. SWOT Analysis
14.3.8.5. Strategic Overview
14.3.9. ICON Central Laboratories
14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.9.2. Test Type Portfolio
14.3.9.3. Financial Overview
14.3.9.4. SWOT Analysis
14.3.9.5. Strategic Overview
14.3.10. INTERLAB Central Lab Services
14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.10.2. Test Type Portfolio
14.3.10.3. Financial Overview
14.3.10.4. SWOT Analysis
14.3.10.5. Strategic Overview
14.3.11. InVitro International
14.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.11.2. Test Type Portfolio
14.3.11.3. Financial Overview
14.3.11.4. SWOT Analysis
14.3.11.5. Strategic Overview
14.3.12. Labcorp/Covance
14.3.12.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.12.2. Test Type Portfolio
14.3.12.3. Financial Overview
14.3.12.4. SWOT Analysis
14.3.12.5. Strategic Overview
14.3.13. LabConnect
14.3.13.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.13.2. Test Type Portfolio
14.3.13.3. Financial Overview
14.3.13.4. SWOT Analysis
14.3.13.5. Strategic Overview
14.3.14. Medpace
14.3.14.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.14.2. Test Type Portfolio
14.3.14.3. Financial Overview
14.3.14.4. SWOT Analysis
14.3.14.5. Strategic Overview
14.3.15. MLM Medical Labs GmbH
14.3.15.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.15.2. Test Type Portfolio
14.3.15.3. Financial Overview
14.3.15.4. SWOT Analysis
14.3.15.5. Strategic Overview
14.3.16. PPD
14.3.16.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.16.2. Test Type Portfolio
14.3.16.3. Financial Overview
14.3.16.4. SWOT Analysis
14.3.16.5. Strategic Overview
14.3.17. Q² Solutions
14.3.17.1. Company Overview (HQ, Business Segments, Employee Strength)
14.3.17.2. Test Type Portfolio
14.3.17.3. Financial Overview
14.3.17.4. SWOT Analysis
14.3.17.5. Strategic Overview
List of Tables
Table 01: Global Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 02: Global Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 03: Global Central Lab Market Value (US$ Mn) Forecast, by Region, 2017-2031
Table 04: North America Central Lab Market Value (US$ Mn) Forecast, by Country, 2017-2031
Table 05: North America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 06: North America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 07: Europe Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 08: Europe Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 09: Europe Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 10: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 11: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 12: Asia Pacific Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 13: Latin America Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 14: Latin America Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 15: Latin America Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 16: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017-2031
Table 17: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by Product, 2017-2031
Table 18: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
List of Figures
Figure 01: Global Central Lab market Value (US$ Mn) Forecast, 2017-2031
Figure 02: Global Central Lab market Value Share, by Product, 2022
Figure 03: Global Central Lab market Value Share, by End-user, 2022
Figure 04: Global Central Lab market Value Share, by Region, 2022
Figure 05: Global Central Lab Market Value Share Analysis, by Product, 2022 and 2031
Figure 06: Global Central Lab Market Attractiveness Analysis, by Product, 2023-2031
Figure 07: Global Central Lab Market Revenue (US$ Mn), by Genetic Services, 2017-2031
Figure 08: Global Central Lab Market Revenue (US$ Mn), by Biomarker Services, 2017-2031
Figure 09: Global Central Lab Market Revenue (US$ Mn), by Microbiology Services, 2017-2031
Figure 10: Global Central Lab Market Revenue (US$ Mn), by Anatomic Pathology/Histology, 2017-2031
Figure 11: Global Central Lab Market Revenue (US$ Mn), by Specimen Management & Storage, 2017-2031
Figure 12: Global Central Lab Market Revenue (US$ Mn), by Special Chemistry Services, 2017-2031
Figure 13: Global Central Lab Market Revenue (US$ Mn), by Clinical Research & Trial Services, 2017-2031
Figure 14: Global Central Lab Market Revenue (US$ Mn), by Others, 2017-2031
Figure 15: Global Central Lab Market, by End-user, 2022 and 2031
Figure 16: Global Central Lab Market, by End-user, 2023-2031
Figure 17: Global Central Lab Market Revenue (US$ Mn), by Pharmaceutical Companies, 2017-2031
Figure 18: Global Central Lab Market Revenue (US$ Mn), by Biotechnology Companies, 2017-2031
Figure 19: Global Central Lab Market Revenue (US$ Mn), by Academic & Research Institutes, 2017-2031
Figure 20: Global Central Lab Market Value Share Analysis, by Region, 2022 and 2031
Figure 21: Global Central Lab Market Attractiveness Analysis, by Region, 2023-2031
Figure 22: North America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 23: North America Central Lab Market Value Share Analysis, by Country, 2022 and 2031
Figure 24: North America Central Lab Market Attractiveness Analysis, by Country, 2023-2031
Figure 25: North America Central Lab Market Value Share Analysis, by Product, 2022 and 2031
Figure 26: North America Central Lab Market Attractiveness Analysis, by Product, 2023-2031
Figure 27: North America Central Lab Market, by End-user, 2022 and 2031
Figure 28: North America Central Lab Market, by End-user, 2023-2031
Figure 29: Europe Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 30: Europe Central Lab Market Value Share Analysis, by Country, 2022 and 2031
Figure 31: Europe Central Lab Market Attractiveness Analysis, by Country, 2023-2031
Figure 32: Europe Central Lab Market Value Share Analysis, by Product, 2022 and 2031
Figure 33: Europe Central Lab Market Attractiveness Analysis, by Product, 2023-2031
Figure 34: Europe Central Lab Market, by End-user, 2022 and 2031
Figure 35: Europe Central Lab Market, by End-user, 2023-2031
Figure 36: Asia Pacific Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 37: Asia Pacific Central Lab Market Value Share Analysis, by Country, 2022 and 2031
Figure 38: Asia Pacific Central Lab Market Attractiveness Analysis, by Country,
Figure 39: Asia Pacific Central Lab Market Value Share Analysis, by Product, 2022 and 2031
Figure 40: Asia Pacific Central Lab Market Attractiveness Analysis, by Product, 2023-2031
Figure 41: Asia Pacific Central Lab Market, by End-user, 2022 and 2031
Figure 42: Asia Pacific Central Lab Market, by End-user, 2023-2031
Figure 43: Latin America Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 44: Latin America Central Lab Market Value Share Analysis, by Country, 2022 and 2031
Figure 45: Latin America Central Lab Market Attractiveness Analysis, by Country, 2023-2031
Figure 46: Latin America Central Lab Market Value Share Analysis, by Product, 2022 and 2031
Figure 47: Latin America Central Lab Market Attractiveness Analysis, by Product, 2023-2031
Figure 48: Latin America Central Lab Market, by End-user, 2022 and 2031
Figure 49: Latin America Central Lab Market, by End-user, 2023-2031
Figure 50: Middle East & Africa Central Lab Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031
Figure 51: Middle East & Africa Central Lab Market Value Share Analysis, by Country, 2022 and 2031
Figure 52: Middle East & Africa Central Lab Market Attractiveness Analysis, by Country, 2023-2031
Figure 53: Middle East & Africa Central Lab Market Value Share Analysis, by Product, 2022 and 2031
Figure 54: Middle East & Africa Central Lab Market Attractiveness Analysis, by Product, 2023-2031
Figure 55: Middle East & Africa Central Lab Market, by End-user, 2022 and 2031
Figure 56: Middle East & Africa Central Lab Market, by End-user, 2023-2031
Figure 57: Global Central Lab Market Share, by Company, 2022
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Central Lab Market